missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Equine IFN-gamma Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
POA
Specifications
| Molecular Weight (g/mol) | 16.7 kDa |
|---|---|
| Name | IFN-gamma |
| Quantity | 25μg |
| Source | E. coli-derived equine IFN-gamma protein Ala25-Gln166 |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
Description
The Recombinant Equine IFN-gamma Protein is derived from E. coli. The Recombinant Equine IFN-gamma Protein has been validated for the following applications: Bioactivity.Specifications
| 16.7 kDa | |
| 25μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |
| IFN-gamma | |
| E. coli-derived equine IFN-gamma protein Ala25-Gln166 | |
| Unconjugated | |
| 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |